Society of Cannabis Clinicians

Canna Talk: Pharmacy Edition -- Featuring Farzana Kennedy, RPh, BSPharm, FACA
2023-01-11 09:00 - 10:00 (America/Los_Angeles)
Join us for “Canna Talk: Pharmacy Edition” on January 11th as we hear from our special guest Farzana Kennedy, RPh, BSPharm, FACA. Dr. Kennedy will discuss her background, how she became involved in cannabis medicine, and answer pertinent questions related to her course module on Cannabis and Policy: Impacts on the Healthcare Environment as part of the new curriculum “Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry.”
This educational webinar series is free for all to attend.
Established cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above.
Speakers:
Farzana Kennedy
Alan Ao
Bobby Vincent
Speaker bio:
Farzana Kennedy, RPh, BSPharm, FACA, is the owner, president, and director of clinical operations of NewLeaf, a West Virginia medical cannabis operator. She is a founding member and past president and pharmacist in charge of Dalitso LLC in Virginia where she managed all cultivation, processing, and dispensary functions.
As a founding board member and the inaugural president of the Virginia Medical Cannabis Coalition (VMCC) Farzana worked to establish and expand Virginia’s medical cannabis program by being involved in the regulatory and legislative process. She is also the chair of the Virginia Pharmacist Association (VPhA) Academy of Medical Cannabis and provides Virginia pharmacists with cannabis industry training and education.
Farzana has over twenty-five years of compounding and clinical pharmacy experience, most notably as the former owner and president of Alexandria Compounding Pharmacy. She is an appointee to the Northern Virginia Regional Human Rights Committee (NVRHRC) and is currently working with Virginia Department of Behavioral Health and Developmental Services as a COVID-19 clinical pharmacist consultant for the mental health and substance use disorder population.
Farzana received her pharmacy degree from Howard University School of Pharmacy. She is a 2023 MS candidate at the University of Maryland Baltimore Graduate School Medical Cannabis Science and Therapeutics program and is a member of several professional pharmacy and cannabis organizations.

Natural Healing Hawaii - A naturopathic lifestyle EXPO
2023-02-04 09:00 - 2023-02-05 18:00 (America/Los_Angeles) | Blaisdell Exhibition Hall
The natural medicine focused expo is a great opportunity for healthcare professionals to collaborate together and discuss current issues, receive educational information, and dialogue on key issues like the Dual Use of Cannabis Task Force panel discussion which includes Ryan’s Law.
While there you can also buy some of the best medical cannabis books and informative material. Please bring strong shopping bags! Hope to see you there!
Register

Quarterly Meeting: Featuring Igor Grant, MD, FRCP(C)
2023-02-17 09:00 - 10:00 (America/Los_Angeles)
Description
Igor Grant, M.D., F.R.C.P. (C)
Distinguished Professor, UC San Diego, Department of Psychiatry
Director, Center for Medicinal Cannabis Research
Dr. Igor Grant is Distinguished Professor and director of the HIV Neurobehavioral Research Program and the Center for Medicinal Cannabis Research at the University of California San Diego (UCSD). Dr. Grant served as Chair of the UCSD Department of Psychiatry from 2014-2019. He is a neuropsychiatrist who graduated from the University of British Columbia School of Medicine (1966), and received specialty training in psychiatry at the University of Pennsylvania (1967-1971), and additional training in neurology at the Institute of Neurology (Queen Square) (1980-1981), London, U.K. Dr. Grant’s academic interests focus on the effects of various diseases on brain and behavior, with an emphasis on translational studies in HIV, and drugs of abuse. He has contributed to approximately 800 scholarly publications and is principal investigator of several NIH studies.
Since 2000, Dr. Grant has been Director of the State of California funded Center for Medicinal Cannabis Research (CMCR). The Center was funded following passage of California Prop 215, the “Compassionate Use Act” which envisioned providing patients under doctor supervision with access to medicinal cannabis in patients whose condition warranted it. California established the CMCR to develop a knowledge base concerning cannabis.
Headquartered at the University of California San Diego (UCSD), the Center has completed several studies on medical cannabis in relation to neuropathic pain and muscle spasticity in Multiple Sclerosis, as well as cannabis and driving impairment. Results of the studies have been published in the scientific literature and are available at: http://www.cmcr.ucsd.edu/, many found evidence of at least short term benefit of medicinal cannabis.
Currently the CMCR is conducting a number of studies on both therapeutic potentials (e.g., with pain, autism, anxiety, metabolic syndrome, and diabetes) and potential risks (e.g., automobile driving) of medicinal cannabis. Studies are beginning to explore modes of administration and specific cannabinoids (e.g., THC, CBD).
CMCR has been the source of authoritative information that is developing on medicinal cannabis and has consulted with the Legislature of the State of California, the Office of the Lieutenant Governor of California (Blue Ribbon Commission’s Regulatory & Tax Structure Working Group), and contributed to the recent National Academies report, “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research” (2017).
Register

SCC and Csequence Journal Club Presents: CBD & the Brain with Jong Rho, MD
2023-03-15 09:00 - 17:00 (America/Los_Angeles)
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s installment will hear Dr. Jong Rho discuss his research on how “Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal Integrity.”
Jong M. Rho, MD
Dr. Rho is a Professor of Neurosciences, Pediatrics and Pharmacology at the University of California, San Diego, and Division Chief of Pediatric Neurology at the Rady Children’s Hospital San Diego. He received an undergraduate degree in molecular biophysics and biochemistry at Yale University, and an M.D. from the University of Cincinnati. Dr. Rho has held prior faculty appointments at the University of Washington (Seattle) and the Seattle Children’s Hospital, the University of California at Irvine, the Barrow Neurological Institute (Phoenix), University of Arizona and Arizona State University, and most recently, the University of Calgary and the Alberta Children’s Hospital. Dr. Rho’s main research interests are the mechanisms underlying the anti-seizure and neuroprotective effects of metabolism-based treatments such as the ketogenic diet. His research activities have been sponsored by research grants from the U.S. National Institutes of Health, Canadian Institutes of Health Research, Brain Canada, and a variety of intramural and extramural public and private sector sources.
Register

International Committee: Cannabis in Thailand by Dr. Shiksha Gallow
2023-03-30 08:30 - 09:30 (America/Los_Angeles)
Dr. Shiksha Gallow presents to the SCC International Committee an update on Medical Cannabis in Thailand. Join us on Thursday, March 30th to hear all of the need to know information on what is happening politically in the Thailand medical cannabis movement, and where clinicians’ rights to practice cannabis medicine stand.
This is a SCC Members Only event. Must log in to your SCC account to register.
Register

SCC and Csequence Journal Club Presents: Adam Abodeely, MD, MBA on Cannabinoids & Gastrointestinal Ailments
2023-04-05 09:00 - 10:00 (America/Los_Angeles)
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s installment will hear Dr. Adam Abodeely discuss his research on cannabinoids & gastrointestinal ailments.
Article:
The minor cannabinoids and their potential implications for conditions of the gastrointestinal system
Register

Roundtable Discussion on the New Certification in Basic Cannabinoid Medicine
2023-04-20 09:00 - 10:00 (America/Los_Angeles)
Register

Special Presentation: Fred Gardner & Dr. Jeffrey Hergenrather on the History of SCC
2023-04-28 09:00 - 10:00 (America/Los_Angeles)
Join us for this Special Presentation with Fred Gardner and Dr. Jeffrey Hergenrather as they recount pivotal moments in California’s medical cannabis movement — Proposition 215, Dr. Tod Mikuriya, and the formation of the California Cannabis Research Medical Group (CCRMG) / Society of Cannabis Clinicians.
Register

Book Launch with Peter Grinspoon, MD -- Seeing through the Smoke: A Cannabis Specialist Untangles the Truth about Marijuana
2023-05-10 09:00 - 10:00 (America/Los_Angeles)
This edition of the SCC / Csequence Journal Club will feature Peter Grinspoon, MD as he discusses his new book (available on April 20, 2023).
You can pre-order the book here.
Description:
Depending on which doctor you speak with, or which websites you read, cannabis could be an appealing, low-risk medicine – even an aid to wellness – or an insidiously addictive drug rotting the brains of our youth. This dissonance confuses young people, distressed patients, and paralyzes politicians, all while inviting dubious sources of information and resulting in uninformed choices, enhanced polarization, and a fragmented national policy.
Seeing Through the Smoke is an unflinching examination at the grossly misunderstood drug that uses data-driven medical science and a critical historical perspective to reveal the truth behind cannabis. In this balanced and measured investigation, Cannabis specialist and Instructor in Medicine at Harvard Medical School Dr. Peter Grinspoon untangles the reality behind cannabis, revealing how we ended up with radically divergent understandings of the drug and pointing a way toward a middle ground that we can all share.
Moving through an illuminating tour of the social history and the medical science behind cannabis, Grinspoon unpacks the layers of disinformation left by a sordid history of government propaganda, racial suppression, and indifference from the medical community to answer questions like:

Is cannabis addictive?
What are its best-established medical uses?
Can cannabis help cure cancer?
How does cannabis affect memory?
How dangerous is cannabis for teens?
Is cannabis a safer treatment for ADHD and PTSD?
What exactly is CBD and how is it different from marijuana?
What are the most concerning side effects?

By focusing on the most critical purported harms—driving, pregnancy, addictiveness, memory—and by focusing on the most commonly cited medical benefits—relieving chronic pain, sleep, anxiety, PTSD, autism, and cancer—Seeing Through the Smoke will help patients, parents, doctors, health experts, regulators, and politicians move beyond biased perceptions and arrive at a shared reality towards cannabis.
Register

CannMed Medical Practicum
2023-05-15 08:00 - 10:00 (America/Los_Angeles) | Marco Island, FL, Marco Island, FL, United States
This workshop is for clinicians exploring the therapeutic potential of medicinal plants, or laypersons looking to understand these medicines at a clinical level. It begins with an exploration of the human endocannabinoid system, and takes a deep dive into how these plants work to alleviate a host of conditions, including dosing, safety, efficacy, side effects, and more. Full day with CME and CEU credits available. We are proud to announce that all of the practicum speakers are long-time members of the SCC.
Register

Quarterly Meeting: Featuring Douglas Bruce, PhD, MSW on Cannabis & HIV
2023-05-26 09:00 - 10:00 (America/Los_Angeles)
Join us for a special Quarterly Meeting featuring Dr. Douglas Bruce on the topic of: The spectrum of cannabis use among young persons living with HIV/AIDS.
Douglas Bruce, PhD, MSW is a public health researcher and earned his PhD in public health from the University of Illinois at Chicago. His mixed methods research focuses on the health behavior of persons living with chronic conditions, including the secondary prevention needs of young persons living with HIV/AIDS, and the role of cannabis in the lives of persons living with chronic disease. He has served as principal investigator on grants from the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Child Health and Human Development. As a program evaluation and development consultant, Dr. Bruce has worked with a number of local organizations, such as the AIDS Foundation of Chicago and Chicago Department of Public Health, as well as national and international organizations, including the Centers for Disease Control and Prevention and the US Agency for International Development.
Register

SCC and Csequence Journal Club Presents: Mark Viner, MD on State Cannabis Legalization and Psychosis-Related Health Care Utilization
2023-06-07 09:00 - 10:00 (America/Los_Angeles)
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s installment will hear Dr. Mark Viner discuss the recently published article, State Cannabis Legalization and Psychosis-Related Health Care Utilization.
Register

UIC 2023: Australian Medical Cannabis Symposium
2023-08-11 08:00 - 2023-08-13 17:00 (America/Los_Angeles) | Brisbane Convention & Exhibition Centre, South Bank Parklands, Brisbane, QLD 4101, Australia
On behalf of United in Compassion (UIC), The Australian Medicinal Cannabis Association (AMCA) and the Society of Cannabis Clinicians Australian Chapter (SCCAC), I am excited to invite you to attend the 2023 Australian Medicinal Cannabis Symposium to be held at the Brisbane Convention and Exhibition Centre from the 11-13 August 2023.

Medical Cannabis Conference
2023-09-02 08:30 - 20:30 (America/Los_Angeles) | Neuroscience Research Building (NRB), UCLA, Neuroscience Research Building (NRB), 635 Charles E Young Drive South, Los Angeles, 90095
This clinical cannabis conference is the first national conference hosted by the Society of Cannabis Clinicians and features authors of the SCC Clinical Training Curriculum. Join us at this exclusive event to hear directly from world-renowned cannabis experts who have combined decades of experience utilizing medical cannabis in their diverse patient populations.
Location: UCLA
Neuroscience Research Building (NRB)
635 Charles E Young Drive South
Los Angeles, CA 90095
ACCME Joint Provider Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Saint John’s Health Center and Society of Cannabis Clinicians. Saint John’s Health Center is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
Saint John’s Health Center designates this Live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Agenda

8:30 am

Welcome: Sherry Yafai, MD
Intro by MC, Dilara Uksup, PhD, PhD

9:00 am
Genester Wilson-King, MD: Cannabis and Endometriosis: It Should be a Treatment Option Now

10:00 am
Patricia Frye, MD: Exploring the Potential Benefits of Cannabis in Autism Spectrum Disorders

11:00 am
Bonni Goldstein, MD: Clinical Effects of Two Important Cannabinoids: CBDV and CBG

12:00 pm
Tim Fong, MD: 2023 Updates to Management of Cannabis Use Disorder

---- 12:30 PM BREAK for LUNCH ----

1:15 pm
Sherry Yafai, MD: Dementia and Palliative Care: Where and how can Cannabis be used?

2:15 pm
Jacqueline Campion: The Department of Cannabis Control’s Academic Research Grant Program

2:45 pm
Reji Varghese, MBC: Medical Board of California Cannabis Recommendations

3:15 pm
Dr. Imani Brown, City of Los Angeles Department of Cannabis Regulation: The Importance of Social Equity in the Licensed Cannabis Market

3:45 pm
Roundtable discussion:
Department of Cannabis Control, Medical Board of California, City of Los Angeles Department of Cannabis Regulations

—- 15 Minute Break —-

4:30 pm
SCC Closing Remarks - Stephen Robinson, MD, MPH

5:00 pm close
Networking & Sponsorship Booth Exhibition

6:00 - 8:00 pm
Happy Hour at The Hideout (The W Hotel) hosted by MedinaCBD: 930 Hilgard Ave Los Angeles CA 90024

Close

Meet the speakers

Bonni Goldstein, MD

Dilara K. Üsküp, Ph.D

Genester Wilson-King, MD

Patricia Frye, MD

Reji T. Varghese, MBC

Stephen Robinson, MD, MPH

Timothy W. Fong, MD

Imani Brown, PhD

Jacqueline Campion

Bonni Goldstein, MD

Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness & Education, a California-based medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions. She completed her internship and residency at Children’s Hospital Los Angeles, where she also served as chief resident. After years of working in the specialty of Pediatric Emergency medicine, she developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend. Over the last 15 years she has evaluated thousands of patients for use of medical cannabis and is recognized as an expert in the clinical application of cannabis therapeutics. She has a special interest in treating children with intractable epilepsy, autism, cancer and other conditions. Her latest book, “Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain” was published in September 2020 by Little, Brown Spark. Dr. Goldstein is currently researching the use of Cannabis-Responsive biomarkers to document objective cannabis treatment efficacy, guide clinical decision-making and improve outcomes.

Close

Dilara K. Üsküp, Ph.D

Dilara K. Üsküp, Ph.D. is an Assistant Professor in Internal Medicine at Charles R. Drew University of Medicine and Sciences and an Investigator in the Department of Family Medicine at the University of California, Los Angeles. Dr. Üsküp is a joint doctoral graduate of the University of Chicago’s Department of Political Science and the Divinity School. She was the first in the University’s history to be awarded both a Ph.D. in political science and a Ph.D. in theology from the Divinity School. She completed her NIH/NIMH training at the UCLA Center for HIV Identification, Prevention, and Treatment Services. Her research investigates the ways religious and political institutions, attitudes, and ideology interacts and shape health behavior to inform public policy. She is also an ordained minister. Her burgeoning research portfolio includes the areas of politics and theology, HIV prevention, cannabis and social equity, and health policy. She collaborates and consultants with faith-based and faith-placed cannabis organizations that are engaged in social justice work around incarceration/citizen reentry, employment/job creation, economic development, health equity, and cannabis social equity. She is co-principal investigator of CaliCANN, a demographic analysis of the state of California cannabis market.

Close

Genester Wilson-King, MD

Genester Wilson-King, MD FACOG is a Board-Certified Obstetrician and Gynecologist with over 20 years of clinical experience providing compassionate and research-driven care to patients. In 2010, she founded Victory Rejuvenation Center (VRC), a private holistic and integrative wellness medicine practice that provides life-transforming management modalities and customized medicines to patients.
She is Vice President of the Society of Cannabis Clinicians, a non-profit that works to empower and educate healthcare providers on the use of cannabis medicine. She is a member of the Special Advisory Board of the Association for Cannabis Health Equity and Medicine, ACHEM, an organization that is a mutual benefit, professional medical association for BIPOC healthcare professionals and students active or interested in cannabinoid medicine and health equity. And finally, she is on the Board of Directors for Doctors for Drug Policy Reform, a national physicians’ association dedicated to the legalization and regulation of cannabis and psychedelics for adults.
A co-author of published articles on the Assessment of the Impact of Cannabis on Female and Male Sexual Function. Dr. Wilson-King is an expert on cannabis use in female health and Hormone Therapy for females and males.

Close

Patricia Frye, MD

Patricia Frye M.D. began her journey with medicinal cannabis as the first evaluating physician for a cannabis telemedicine platform, HelloMD. This was her first introduction to the use of cannabis as medicine and it proved to be an invaluable and career-changing experience. Intrigued by the testimony of thousands of patients and what she learned from the scientific literature, Dr. Frye went on to become professionally certified in Cannabis Science and Medicine by the University of Vermont School of Medicine.
Now in private practice, Dr. Frye focuses on the role of cannabis in the management of chronic pain, inflammation, autoimmunity, neurodegenerative disorders, autism, seizure disorders, and psychiatric conditions. She works closely with patients and their referring clinicians to develop sound treatment plans that are based on both observational and scientific evidence.
Dr. Frye earned her medical degree at the University of Maryland School of Medicine, where she also trained in pediatrics, and is certified by the American Board of Pediatrics. After completing her pediatric residency, she trained in Anesthesiology at Baylor College of Medicine where she gained experience working with adult patients in medical pain management and pain management procedures.
During her many years at Kaiser Permanente in Southern California her practice focused on children and teens with autistic spectrum disorder, learning and developmental disabilities, school problems, and behavior issues. She has served as a volunteer for several organizations which include the St. Mary’s AIDS Care Team, Phoenix House, an in-patient drug rehabilitation program for adolescents, Head Start Committee on Health, and Piedmont CASA where she served as an advocate for children in the family court system due to abuse or neglect.
Dr. Frye lectures internationally, educating medical providers, patient groups, policy makers, businesses, and government agencies on the endocannabinoid system and medical benefits of the cannabis plant. She serves on the Cannabis Trade Federation Task Force on Diversity, Equity, and Inclusion and the board of the Society of Cannabis Clinicians. In 2018 she authored the book “The Medical Marijuana Guide: Cannabis and Your Health”.

Close

Reji T. Varghese, MBC

Mr. Varghese is serving as Deputy Executive Director of The Medical Board of California (MBC) for the past two years and seven months and as of February 17, 2023 the Board appointed him to the position of Interim Executive Director. Prior to joining MBC, he served, for 10 (ten) years, The Oklahoma Board of Medical Licensure and Supervision (OMB) in the capacity of Deputy Executive Director. He started working at OMB from November 1989 and served in different capacity, various positions, and departments. In total he has over 33 years of experience in medical regulatory field.
He obtained bachelor’s degree in economics/commerce from MG University, India.
Varghese is an active member of California Department of Consumer Affairs’ DEI steering committee. He also served on the Board of Directors of; The Telehealth Alliance of Oklahoma, member of The Allied Tele-health sub-committee for the Board, South Indian Cultural Association of Oklahoma.
Also, served as Board member of several organizations to include Putnam City Public Schools Oklahoma, Oklahoma Public Purchasing Association, St. George Syriac Orthodox Christian Church, Council representative to American Archdiocese of Syriac Orthodox Churches, Director of National Sunday School Association.

Close

Stephen Robinson, MD, MPH

Dr. Stephen S. Robinson grew up in Newark, NJ and graduated from Reed College in Portland, Oregon and the University of Washington Medical School in Seattle. Dr. Robinson completed his MPH at Johns Hopkins School of Hygiene and Public Health.
His interest in both public health and global health became a lifelong commitment after his first visit to Cuba in the early ’70s. He completed his residency in internal medicine at Harlem Hospital Center and later served as a medical team leader to Ghana and Liberia with Operation Crossroads Africa.
In New York City, Dr. Robinson worked within the Sophie Davis School at the City College of New York for 15 years, to establish the CUNY Medical School. Esteemed colleagues included the late Dr. George I. Lythcott. During his tenure with the City University, Robinson also served as the interim director of the Physician Assistant Program at Harlem Hospital Center.
After working as Medical Director with Georgia’s Primary Care Assn., he left the US for five years and worked in Tanzania, setting up an exchange program between the Institute for Medical Research in Tanzania and the Public Health Sciences Institute at Morehouse College. While there, he also worked with Columbia University’s Mailman School of Public Health evaluating health facilities for their readiness to provide HIV/AIDS care and treatment.
Since his move to Oakland, California in 2010, Dr. Robinson has been evaluating patients for their use of medical cannabis. He participated on panels at numerous cannabis-related conferences and delivered presentations on cannabis’ medicinal benefits and dosing strategies to both professional and lay audiences. Dr. Robinson contributed to the revision of the Medical Board of California’s “Guidelines for the Recommendation of Cannabis for Medical Purposes.” He has been a board member of the Society for Cannabis Clinicians, and currently serves as president of the organization.

Close

Timothy W. Fong, MD

Dr. Fong is a Professor of Psychiatry at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA. He is board certified in adult and addiction psychiatry.
He is the co-director of the UCLA Gambling Studies Program. The purpose of this program is to examine the clinical characteristics of gambling disorder in order to develop effective, evidence-based prevention and treatment strategies.
Dr. Fong is also a member of the Steering Committee of the UCLA Center for Cannabis and Cannabinoids whose mission is to address the most pressing questions related to the impact of cannabis legalization through rigorous scientific study and discourse across disciplines.
He is the Director of the UCLA Addiction Psychiatry Consultation Service and an an attending physician in the UCLA Addiction Psychiatry Clinic.

Close

Imani Brown, PhD

Dr. Imani Brown is an urban policy and economic development professional with more than 25 years’ experience in the areas of public policy, sustainable urban land use, government relations and small business development. She is currently the Social Equity Program Director for the City of Los Angeles Department of Cannabis Regulation. Her programs’ focus is equity business development, education, technical assistance, grants, pro bono & low bono legal services, workforce development and the advocacy and creation of equity centered policy reforms.
For many years she served as the Managing Partner for a smart growth, sustainable land use development company. Dr. Brown was formerly the Executive Director of External Partnerships of Government & Civic Engagement at USC, where she was the principle negotiator for the Community Benefits Agreement package for the University Village, a multibillion dollar economic development project. As Associate Vice President of University & Government Relations at California State University Dominguez Hills, she served as the chief liaison for the University in the development of the privately owned Stub Hub Sports Arena (Currently Dignity Health Sports Park). She served as Chief Deputy of Small Business, Transportation and Housing for the late Congresswoman Juanita Millender-McDonald of the 37th Congressional District, where she created small business incubators and workforce development opportunities for communities impacted by the Alameda Corridor Project. She has negotiated multi million dollar professional services contracts in the public and private sectors and co
founded The Vendor Relations Department for the Metropolitan Transportation Authority (MTA).
She has served on numerous non-profit boards, and chaired the board of directors for T.H.E Clinics of Los Angeles, The Ashley Morgan Spiller Cancer Foundation, and the Gordon/Brown Fellowship. Dr. Brown was most recently appointed by the State of California to serve on the Board of the Cannabis Advisory Committee.
She has produced art events for international artists, and raised funding and awareness for battered women and children. She promotes financial literacy and mentors college bound urban youth in Los Angeles. Dr. Brown is passionate about building an equity centered licensed Cannabis industry at the local, state, federal and international levels.

Close

Jacqueline Campion

Jacqueline Campion is the Deputy Director of Policy and Research at the California Department of Cannabis Control (DCC), the state agency that licenses and regulates cannabis businesses. The Policy and Research Division of DCC develops regulations and policy recommendations that advance the sustainability, safety, and equity of the legal cannabis market and benefit all Californians. To support informed policy decisions, this division conducts research, administers research grants, and facilitates collaboration with stakeholders, other state agencies, and global government entities.

Close

Register

Kickoff Event for SCC Latin American Chapter & Spanish Courses
2023-09-13 09:00 - 10:00 (America/Los_Angeles)
Join us for a special kickoff event to celebrate the re-launch of the Latin American (LATAM) Chapter as well as the new courses available in Spanish!
Este paquete de 5 cursos cubre la ciencia esencial sobre el sistema endocannabinoide, la botánica, la farmacología, el análisis de laboratorio y la dosificación y administración del cannabis medicinal.

Descripción general del Sistema Endocannabinoide
Botánica, Ecología y Fitoquímica del Cannabis
Farmacología del cannabis: farmacocinética, farmacodinámica e interacciones farmacológicas
Análisis de laboratorio: Aseguramiento de la calidad y productos de cannabis
Dosis y administración de la medicina del cannabis

Note: the event will be in Spanish.
Register

International Committee: Cannabis in India by Dr. Sayed Tahir
2023-09-21 09:00 - 10:00 (America/Los_Angeles)
Dr. Sayed Tahir presents to the SCC International Committee an update on Medical Cannabis in India. Join us on Thursday, September 21st to hear all of the need to know information on what is happening politically in the Indian medical cannabis movement, and where clinicians’ rights to practice cannabis medicine stand.
Register

Cannabinoids & Kidney Function by Joshua L. Rein, DO, FASN - SCC and Csequence Journal Club
2023-10-04 09:00 - 10:00 (America/Los_Angeles)
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s edition will feature Dr. Joshua Rein as he discusses his research and clinical experience with cannabis & kidney function.

A Retrospective Cohort Study That Examined the Impact of Cannabis Consumption on Long-Term Kidney Outcomes
The nephrologist’s guide to cannabis and cannabinoids
Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD

Register

International Roundtable of Clinical Case Presentations
2023-10-11 09:00 - 10:30 (America/Los_Angeles)
Join us for this one-of-a-kind event as we host clinicians from around the globe to discuss clinical case studies of their medical cannabis patients.
Presenters:

Ross Coomber, MD (UK): Treating hallucinations
Guilherme Nery, MD (Brazil): Medical cannabis as performance enhancer in amateur sportsmen
Whittney Wacker, RN (US): Restoration of suspected receptor down regulation through education
Jeff Hergenrather, MD (US): Multiple Sclerosis, an endocannabinoid deficiency disease
Dustin Sulak, DO (US): Pediatric pain and self-injury in Bohring-Opitz Syndrome

Attend live to participate in the Q&A.
All SCC members will have access to the recording following the event.
Register

Asia International Hemp Forum
2023-11-22 11:00 - 2023-11-23 18:00 (Asia/Bangkok)
SCC Board Member, Dr. Shiksha Gallow, will be representing the Society of Cannabis Clinicians and sharing her clinical perspective at this international event.
The “Asia International HEMP Expo” is the first and only international event in Thailand for businesspeople and industrialists seeking information, crucial benefits, greater awareness and sustainable solutions for the future of hemp which has already been unlocked and legalized in Thailand.
Thailand holds the distinction of being the first country in Asia to legalize the use of hemp, making it an attractive destination for investment in the hemp industry. Its prime location and favorable conditions for cultivation provide a strong foundation for entrepreneurs. The country’s notable governmental support has further solidified Thailand’s position as a pioneer nation in hemp planting and processing. As a result, domestic entrepreneurs have been able to advance rapidly in both fiber and extract development.
The Thai Industrial Hemp Trade Association (TiHTA) serving as the official agency that collaborates with the government to formulate and implement policies related to hemp use, has forged a partnership with the Queen Sirikit National Convention Center, the most modern and newest convention center in Southeast Asia, to organize the “Asia International Hemp Expo and Forum 2023”. The expo is scheduled to take place during 22-25 November 2023.
The “Asia International Hemp Expo” is the very first trade exhibition for hemp industry in Asia which is organized annually. In 2023, this expo is the second edition which will showcase the latest in cutting-edge hemp technology, materials and equipment for planting, extracting and processing, with the aim of facilitating the establishment of production bases in Thailand. In addition, it will provide a valuable platform for comprehensive business negotiations among raw material suppliers and manufacturers of processed hemp products, covering the entire supply chain from upstream to downstream as well as opportunities for export channels.”
The expo will focus on the following primary industries: medical supplies, food and beverages, cosmetics and spas, fashion apparel, composite products, building materials (such as HEMP Crete), and other alternative materials.
Register

National Interdisciplinary Cannabis Symposium (Educating one another)
2023-12-01 17:00 - 2023-12-03 00:00 (America/Los_Angeles) | PORTLAND, OREGON
Event details:
NATIONAL INTERDISCIPLINARY CANNABIS SYMPOSIUM 2
Educating One Another
1 – 3 DECEMBER 2023
PORTLAND, OREGON
There are now several pending Congressional Bills related to cannabis including decriminalisation and rescheduling of the drug.
Thirty- eight states have some form of medical marijuana. 23 States, D.C. Guam, Northern Mariana Islands, and Tribal nations now have adult use marijuana laws with many others exploring legislation for recreational marijuana for 2023-24 .
These continued changes in laws are impacting our courts and society. It is also creating a dynamic and sometimes confusing landscape for various disciplines including Law Enforcement, Judges, The Legal Profession, In House Counsel, Drug Court Professionals, the Drug and Alcohol Testing Industry, Academia, and Human Resource Associations & Organisations.
The Symposium brings together all of these disciplines who bring with them a variety of viewpoints. The Byline for the Symposium is therefore “Educating One Another.” This year we have extended our Partnerships and have broadened the participation to include toxicologists, MDs and attorneys. We also have a professional Facilitator for the discussion breakouts and an inaugural Award called the Symposium Education Award (SEA). We hope that you join and enjoy the Symposium!
The revenue generated from this Symposium will be used to cover the cost and seed money. Any excess funds will be donated to 501(C)(3)s. Thanks to all who have made a contribution to it.
**Register as a Society of Cannabis Clinicians Members to receive a discount of over 25% on the registration fee!**

Cannabis Nursing is a Speciality - Meet & Greet Event
2023-12-07 12:00 - 13:00 (America/Los_Angeles)
Join us at the Cannabis Nurses Speciality Meet & Greet Event!
We will be highlighting the announcement from the American Nurses Association that officially recognizes Cannabis Nursing as a Specialty Nursing Practice and sharing resources for cannabis nursing education.
This event is free and open to all.
Discussion Panel:

Windi Muraszka, CNM, NP, MS (SCC Board Member)
Elisabeth Mack RN, BSN, MBA (Holistic Caring Founder & CEO)
Sherri Mack RN, BSN (Founder of The Green Nurse)

Topics to be Covered:

A discussion of Cannabis Nursing being designated as a Speciality in Nursing by the American Nurses Association
A tour of the Holistic Caring Network platform that houses these new programs
A preview of the Cannabis Nurse Health Coach (CNHC) Curriculum offered through our new Holistic Caring partnership
A discussion of the CNHC Monthly Mastermind to deep dive into clinical and business development for members
A primer on Licensing, and what that means to participants of this new paradigm in healthcare

Come hear about this groundbreaking decision to officially recognize cannabis nursing practice as a nursing specialty and learn how to become a Cannabis Nurse through the new curriculum we will be offering in partnership with Holistic Caring.
Register

CannaConnect: January Members Call (Hosted by SCC President, Dr. Stephen Robinson)
2024-01-18 01:30 - 02:30 (America/Los_Angeles)
About
Welcome to our new members-only series, CannaConnect!
Join us for these monthly member connection calls hosted by a Board Member. The SCC President Dr. Stephen Robinson will kick us off in January 2024! Click the Zoom link below to attend. We invite all members to come introduce yourselves, ask questions, and offer or look for mentorship among other SCC members.
Each month will offer an interactive blend of networking, clinical case discussions, and the latest in cannabis news. Connect with fellow SCC members, find or offer mentorship, share insights on clinical practices, and welcome new members to our thriving community.
Stephen Robinson, MD, MPH
Dr. Stephen S. Robinson grew up in Newark, NJ and graduated from Reed College in Portland, Oregon and the University of Washington Medical School in Seattle. Dr. Robinson completed his MPH at Johns Hopkins School of Hygiene and Public Health.
His interest in both public health and global health became a lifelong commitment after his first visit to Cuba in the early ’70s. He completed his residency in internal medicine at Harlem Hospital Center and later served as a medical team leader to Ghana and Liberia with Operation Crossroads Africa.
In New York City, Dr. Robinson worked within the Sophie Davis School at the City College of New York for 15 years, to establish the CUNY Medical School. Esteemed colleagues included the late Dr. George I. Lythcott. During his tenure with the City University, Robinson also served as the interim director of the Physician Assistant Program at Harlem Hospital Center.
After working as Medical Director with Georgia’s Primary Care Assn., he left the US for five years and worked in Tanzania, setting up an exchange program between the Institute for Medical Research in Tanzania and the Public Health Sciences Institute at Morehouse College. While there, he also worked with Columbia University’s Mailman School of Public Health evaluating health facilities for their readiness to provide HIV/AIDS care and treatment.
Since his move to Oakland, California in 2010, Dr. Robinson has been evaluating patients for their use of medical cannabis. He participated on panels at numerous cannabis-related conferences and delivered presentations on cannabis’ medicinal benefits and dosing strategies to both professional and lay audiences. Dr. Robinson contributed to the revision of the Medical Board of California’s “Guidelines for the Recommendation of Cannabis for Medical Purposes.” He has been a board member of the Society for Cannabis Clinicians, and currently serves as president of the organization.
Must be a member to attend these monthly calls; you can learn more about joining here.
Register

CannaConnect: February Members Call (Hosted by Dr. Shiksha Gallow)
2024-02-07 22:00 - 23:00 (America/Los_Angeles)
About
Welcome to our new members-only series, CannaConnect!
Join us for these monthly member connection calls to introduce yourself, ask questions, and discuss with other members. SCC Board Member, Dr Shiskha Gallow, will be hosting our February 2024 call!
Each month will offer an interactive blend of networking, clinical case discussions, and the latest in cannabis news. Connect with fellow SCC members, find or offer mentorship, share insights on clinical practices, and welcome new members to our thriving community.
Shiksha Gallow, PhD
Dr. Shiksha Gallow is a pioneer in the Medical cannabis industry globally. She serves as the first and only South African on the Board of Directors at the Society of Cannabis Clinicians in the USA. She is the Medical Director of Holistic Healing and Cannabis Research Council in South Africa and Vertical High in Thailand. She holds a degree in Bio- Medicine and is qualified in Clinical Pathology which she achieved Cum Laude. Additionally she has a Masters in Medical Science, Masters in Public Health Medicine, MBA, and two PHDs. She has a Doctorate in Medicine and a PHD in Business Leadership and is now completing her third PHD (Medical Science) in medical cannabinoid research. Her passion lies in healing patients and she completed her Dispensing of Medicines qualification as well. Among all her academic qualifications, she is an Ethnomedicine practitioner, Ayurvedic practitioner and Cannabis Clinician. She has consolidated many natural medicinal protocols, which include cannabinoids and has conducted large scale research studies on these protocols. Dr. Gallow is the principal investigator of the first cannabis clinical trial in South Africa, which investigates the replacement of opioids with medical cannabis. She is also involved in research on South African landrace chemovars for specific pathologies.
Dr. Gallow is an international author and published five academic books and many articles. She is appointed as a peer reviewer for AOSIS international. She is an international speaker at many events and conferences such as Cannatech, Medical Research, SAMA, HPCSA, Cannabis Expo etc. Dr. Gallow is an advisor to local and national governments in South Africa and represents part of the Strategic advisory team for medical cannabis. She was recently appointed on the EXCO of the BRICS strategic team representing medical cannabis in South Africa.
Must be a member to attend these monthly calls; you can learn more about joining here.
Register

Journal Club: Dr. Joe D. Goldstrich on the Cannabis Cancer Connection
2024-03-06 09:00 - 10:00 (America/Los_Angeles)
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s installment will hear Dr. Joe D. Goldstrich discuss a chapter from his new book, The Cannabis Cancer Connection: “When To Think Twice about Using THC (for cancer).”
When to Think Twice About Using THC
Every time I suggest a new therapeutic cannabinoid protocol for a specific tumor type, a phrase from the Hippocratic Oath I took almost 60 years ago pops into my head; “I will follow that system of regimen which, according to my ability and judgment, I consider for the benefit of my patients, and abstain from whatever is deleterious and mischievous.” Abstaining from the deleterious and mischievous has come to be known as “first, do no harm.”
While the readers of this book can in no way be considered my patients, the principle of doing no harm is always my primary concern.
Information on the Internet about the use of cannabis to treat cancer would leave patients to believe cannabis and THC are likely to be antineoplastic for any cancer. In my experience, that may not be true.
Because of the absurd, ridiculous, and cruel Schedule I classification of cannabis, there are no clinical trials documenting the benefits and/or potential harms of cannabis use in treating cancer. Without clinical trials, patients and medical professionals are limited and forced to use the best research available, preclinical research. Most preclinical research shows that cannabis acts as an effective antineoplastic agent, and its use results in the death of cancer cells and the shrinkage of tumors.
But in the interim, before the results of clinical trials, it is imperative first to do no harm.
In this presentation we will take a closer look at:

HPV-Related Squamous Cell Carcinoma of the Head & Neck (SCCHN)
Squamous Cell Carcinoma of the Esophagus (SCCE)
Cancer of the Uterine Cervix
Anal Cancer
Renal Cell Carcinoma (RCC)
Hepatocellular Carcinoma (HCC)

Excerpted from The Cannabis Cancer Connection by Joe D. Goldstrich, MD, FACC
Joe D Goldstrich, MD, FACC
Joe D Goldstrich, MD, FACC grew up in Dallas, Texas and graduated from Southern Methodist University with a bachelor’s degree in mathematics. After working as a mathematician for the US Navy, Dr. Goldstrich attended the University of Texas Southwestern Medical School in Dallas where as a senior medical student he was present in trauma room and participated in the futile attempt to save president John F. Kennedy on November 22, 1963.
He subsequently became board-certified in Internal Medicine, Cardiovascular Diseases and Clinical Lipidology. In 1978 Dr. Goldstrich met Nathan Pritikin, the father of the Pritikin diet, and became the chief cardiologist at the Pritikin clinic and later the medical director of the Pritikin program.
He practiced preventive cardiology and integrative medicine until his retirement in 2010. In 2013 he accepted a position at a clinic that provided medical cannabis recommendations in Oakland, California. In 2014 he personally worked with approximately 3500 patients who used medical cannabis to treat their medical condition. From these patients, he learned the beauty and efficacy of medical cannabis. During that time, he saw a presentation by Mara Gordon that detailed shrinkage of brain tumors that could be attributed to cannabinoid therapy. At that moment he knew that treating cancer with cannabinoids would become his life’s work.
Dr. Goldstrich has been a member of the Board of Directors of the Society of Cannabis Clinicians since 2016.
Recent Presentations

Presentation: The Use of Medical Cannabis in the Treatment of PTSD, University of Chicago Medicine, Orlando, Florida, October 2021
Presentation: Using Cannabis to Treat Cancer, Santa Barbara Medical Cannabis Conference & Expo, Santa Barbara, CA, May 2019
Moderated panel on Cannabis and Cancer, CannMed 2018, Los Angeles, CA (24 October 2018) https://www.youtube.com/watch?v=TK3fPS15-As
Presentation: Unleashing the Full Potential of Cannabis’ Antineoplastic Benefits, Reimagining the Concept of Full Extract, Marijuana for Medical Professionals, Denver, CO (15 October 2018)

Register

CannaConnect: March Members Call (Hosted by Dr. Dustin Sulak)
2024-03-08 09:00 - 10:00 (America/Los_Angeles)
About
Welcome to our new members-only series, CannaConnect!
Join us for these monthly member connection calls to introduce yourself, ask questions, and discuss with other members. SCC Board Member, Dr. Dustin Sulak, will be hosting our March 2024 call!
Each month will offer an interactive blend of networking, clinical case discussions, and the latest in cannabis news. Connect with fellow SCC members, find or offer mentorship, share insights on clinical practices, and welcome new members to our thriving community.
Dustin Sulak, DO
Dustin Sulak, D.O. is a traditional osteopathic general practitioner and expert in integrative medicine. His clinical practice focuses on treating refractory conditions in adults and children. Dr. Sulak received bachelor degrees in nutrition science and biology from Indiana University – Bloomington. He received his medical degree from the Arizona College of Osteopathic Medicine in 2008. Dr. Sulak is an internationally-renowned expert in medical cannabis and frequently educates clinicians, industry professionals, and patients at conferences, webinars, and retreats. In addition to co-authoring eight peer-reviewed publication on medical cannabis, he is the author of a foundational text on the clinical use of cannabis, Handbook of Cannabis for Clinicians: Principles and Practice, published in 2021. He is co-founder of Healer, a medical cannabis education and products company, and has served on the SCC’s board of directors since 2015.
Must be a member to attend these monthly calls; you can learn more about joining here.
Register

Journal Club: Dr. Ana Hounie Case Report on Progressive Supranuclear Palsy Patient
2024-04-02 09:00 - 10:00 (America/Los_Angeles)
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s installment will hear Dr. Ana Hounie discuss her recently published case study, Neurological Improvement with Medical Cannabis in a Progressive Supranuclear Palsy Patient: A Case Report.
Ana Hounie, MD, PhD
Founder and President of the Brazilian Association of Endcannabinology (Ambcann)
Founder and member of the consultative council of the Pan-American Medical Cannabis Association
Dr. Ana Hounie has a degree in Medicine from the Federal University of Pernambuco (1994) and a PhD in Sciences, in the area of Psychiatry, from the University of São Paulo-FMUSP (2003). She completed her postdoctoral studies at the USP Faculty of Medicine. She works mainly in the care and research of Obsessive-Compulsive Disorder and Tourette Syndrome, having published a book on the latter syndrome, in which she is one of the main experts in Brazil. She is currently dedicated to the study of medicinal cannabis, with which she has clinical experience since 2016, conducting courses and lectures on the topic.
Register

CannaConnect: April Members Call (Hosted by Windi Muraszka)
2024-04-12 09:00 - 10:00 (America/Los_Angeles)
About
Welcome to our new members-only series, CannaConnect!
Join us for these monthly member connection calls to introduce yourself, ask questions, and discuss with other members. SCC Board Member, Windi Muraszka, will be hosting our April 2024 call!
Each month will offer an interactive blend of networking, clinical case discussions, and the latest in cannabis news. Connect with fellow SCC members, find or offer mentorship, share insights on clinical practices, and welcome new members to our thriving community.
Windi Muraszka, CNM, NP, MS
Windi Muraszka graduated Hunter College of Nursing of the City University of New York in 1992 and began working in Manhattan’s Upper East Side as a labor and delivery nurse. She attended Frontier School of Midwifery and Family Nursing deep in the Appalachian Mountains of Kentucky, the birthplace of American Nurse-Midwifery. Her midwifery clinical training occurred at a Bronx Birthing Center, a Manhattan Planned Parenthood clinic, and at Maimonides Medical Center in Brooklyn. She then completed a Master’s Program at Stony Brook University of The State University of New York. Upon graduation, she took a job at Wyckoff Height Medical Center, a Brooklyn community hospital where she has welcomed babies since 1996.
In 2014 Windi worked in concert with several physicians to establish a visionary new type of private practice maternity care service. The Augury for Women’s Health and Midwifery was a true coupling of the science of medical-based maternity care with the humanistic centering of a midwifery approach. This amalgam of ancient knowledge and sacred midwifery lineage married quite well with a modern evidence-based approach to women’s health and wellness, pregnancy, birth, and breastfeeding and has become an answer to the prayers of so many women and families. Windi has worked with thousands of women through the years, catching over 2800 babies and now serving two full generations.
Windi became intrigued with the healing and wellness-supporting properties of cannabis when several members of her close family and friend circle were diagnosed with cancer and auto-immune disorders. After completing the New York State training program for medical cannabis providers, she decided to delve deeper into this field and matriculated in the first university program in the country offering professional medical cannabis training, the University of Maryland’s Medical Cannabis Science and Technology Master’s program.
Windi continues to serve the women and families of New York City in her role as midwife and nurse practitioner, now offering medical cannabis as one of the many tools she uses in optimizing their health. She looks forward to continuing the vision of the Society of Cannabis Clinicians by focusing on matters highly pertinent to women’s health and the nurturing of the next generation.
Must be a member to attend these monthly calls; you can learn more about joining here.
Register

SCC Special Webinar: The Future of Cannabis Nursing
2024-04-17 09:00 - 10:00 (America/Los_Angeles)
About
Join us for this special event where experienced SCC nurses discuss their path that led them to cannabis nursing, and the new roles they are developing to create pathways and opportunities for the integral role of nurses within integrative care teams.
Moderator: Windi Muraszka, DNP, CNM, WHNP, SCC Board Member
Panelists:

Katherine Golden, RN/CEO/ED & Founder of Leaf411
Heather Manus, RN, Founder of the Cannabis Nurses Network
Dawn-Marie Streensa, LPN, SDC, QA, SCC
Laura Barrett, MBA, BSN, RN
Kristie Peggins, DNP, AGACNP-BC, FNP-C, MS Medical Cannabis Science and Therapeutics

Register

CannaConnect: May Members Call (Hosted by Dr. Katia Tonkin)
2024-05-08 09:00 - 10:00 (America/Los_Angeles)
About
Welcome to our new members-only series, CannaConnect!
Join us for these monthly member connection calls to introduce yourself, ask questions, and discuss with other members. SCC Board Member, Dr. Katia Tonkin, will be hosting our May 2024 call!
Each month will offer an interactive blend of networking, clinical case discussions, and the latest in cannabis news. Connect with fellow SCC members, find or offer mentorship, share insights on clinical practices, and welcome new members to our thriving community.
Katia Tonkin, MBBS, MD, FRCP(UK), FRCPC
Katia Tonkin, MBBS, MD, FRCPC, FRCP (UK) is a medical oncologist who worked at The Cross Cancer Institute in Edmonton Alberta Canada for 20 years and in London, Ontario Canada for six years prior to that. She did her medical oncology training at The Princess Margaret Hospital in Toronto Ontario and has dual UK and Canadian oncology qualifications. Dr. Tonkin was involved for 30 years in clinical trials that specialized in breast and gynecological cancers.
She has a master’s degree from two years spent in the lab studying chemotherapy and radiation effects in immune compromised mice.
She became interested in medical cannabis in 2016 as many patients started asking about cannabis. After researching into it, Dr. Tonkin felt cannabis was likely to help many patients with a wide variety of problems.
She started treating patients in April 2017 and wants to pursue clinical research to further medical knowledge into appropriate uses of medical cannabis. Dr. Tonkin’s goal is to help uncover the true benefits and side effects of cannabis beyond the already very useful pragmatic clinical approach.
Must be a member to attend these monthly calls; you can learn more about joining here.
Register

CannaConnect: June Members Call (Hosted by Dr. Bobby Vincent)
2024-06-05 09:00 - 10:00 (America/Los_Angeles)
About
Welcome to our members-only event series, CannaConnect!
Join us for these monthly member connection calls to introduce yourself, ask questions, and discuss with other members. SCC Board Member, Dr. Bobby Vincent, will be hosting our June 2024 call!
Each month will offer an interactive blend of networking, clinical case discussions, and the latest in cannabis news. Connect with fellow SCC members, find or offer mentorship, share insights on clinical practices, and welcome new members to our thriving community.
Bobby Vincent, III, PharmD, RPh
Bobby Vincent, III, PharmD, RPh is a Clinical Cannabinoid Pharmacotherapist born and raised in Richmond, Virginia. Dr. Vincent is driven by a passion to bridge the medical cannabis industry with communities in need. Dr. Vincent currently serves the northern Virginia and Washington, D.C. metropolitan area as a pharmacist and medical consult– providing care for hundreds of cannabis patients. Dr. Vincent is the founder of Cannabis Health Alliances, LLC., building partnerships to advance therapy, policy and patient accessibility. He also serves as the Communications Chair for the Virginia Pharmacists Association’s Academy of Medical Cannabis and a member of the organizations Task Force for Racial Diversity, Equity, and Inclusion.
Dr. Vincent is a graduate of Hampton University where he obtained a Doctor of Pharmacy degree. He is currently pursuing a Masters of Cannabis Science and Therapeutics at the University of Maryland, Baltimore – the first degree of its kind available in the United States. He has experienced a host of unique learning opportunities, including time abroad in Thailand, United Arab Emirates, and the Philippines as a medical volunteer. Dr. Vincent also spent time with the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) Office of Science Policy and Communications as a pharmacy intern.
Dr. Vincent was honored as a Virginia Pharmacists Association “10 Under 10” award recipient, recognizing upcoming pharmacists advancing health initiatives in their community. Dr. Vincent is also a recipient of the United States Public Health Service (U.S.P.H.S.) Excellence in Public Health Pharmacy Award. He uses his platform to advocate for the involvement of pharmacists in the medical cannabis industry. He also speaks to the importance of training the next generation of healthcare professionals on the medical advantages of cannabis, personally mentoring pharmacy students across the US. As an advocate, educator, and pharmacist, Dr. Vincent is enthusiastic about the evolution of cannabis as a medicine and the opportunities it continues to open up for patient care.
Must be a member to attend these monthly calls; you can learn more about joining here.
Register
